Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Trial of Automated AI-based System for Early Diagnosis of Diabetic Retinopathy Using Retinal Color Imaging

NCT05324189 is registered in ClinicalTrials.gov with The New York Eye & Ear Infirmary as lead sponsor.

NCT NCT05324189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Trial of Automated AI-based System for Early Diagnosis of Diabetic Retinopathy Using Retinal Color Imaging
Lead sponsor
The New York Eye & Ear Infirmary
Phase
Observational
Overall status
Unknown status
Start date
April 18, 2022
Completion date
December 1, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy